Clay Siegall’s Impact

NFL free agency is just a few weeks away and teams are working hard to prepare. One of this years biggest names on the market is Redskins quarterback Kirk Cousins. Cousins is clearly the best quarterback available and has been linked to a number of teams. One of those teams is the Cleveland Browns. Clay Siegall recently commented on the possibility of Cousins playing for the Browns. Siegall was quoted as saying ” A Cousins-Browns pairing doesn’t make sense, even for one year.” The Browns have had turmoil in their front office for years. With so many other options in the league like he Jaguars, Giants, and Jets, Siegall’s statement appears to be spot on.

Clay Siegall has been making his presence felt in the business world for quite some time. Siegall is the co-founder of Seattle Genetics and also serves as the the company’s President, CEO. Siegall holds degrees from both George Washington University and the University of Maryland. His resume is impressive and includes working with some well known companies like AbbVie and Pfizer. His work has helped to produce some of the most advanced cancer therapies while generating more than three hundred million dollars.

Clay Siegall is responsible for nearly seventy scientific papers and he holds nine patents. He has served in numerous leadership roles including being a member of the Board of Scientific Counselors for the Cancer Treatment. His work has been recognized several times. He was given the Pierce Award in 1995 for his work with targeted toxins. Just a few years he was a Entrepreneur of the Year award finalist for healthcare. Clay Siegall has a tremendous track record. He is sure to continue making an impact for years to come.